CWRU, Cleveland Clinic win $1.3 million grant to start Rett syndrome trial

A team of researchers at Case Western Reserve University and the Cleveland Clinic will use a $1.3 million grant from the Rett Syndrome Research Trust to launch a clinical trial of a new treatment for the rare genetic disorder, which shares some symptoms with autism. The Phase 2 clinical trial, which may launch as early as this spring, will test the effectiveness of low-dose ketamine in treating the symptoms of Rett syndrome, which can include characteristic hand movements, breathing difficulties, difficulty walking, and loss of social interaction and communication.

http://ift.tt/1LPMLtv